FOXP3 and neoplasm: The conflicting results from different studies suggest that FOXP3+ T cells act differently in different anatomical subsites and tumor stages [69], changing to pro-tumorigenic cells as the tumor progresses, or that it might depend on their origin, with only FOXP3+ T cells recruited from the peripheral blood involved in tumor elimination [57].